Building Biotech Champions: From Discovery to Global Impact
Building Biotech Champions: From Discovery to Global Impact
Hosted by Superlab Suisse Basel & Zühlke
About the Event
Superlab Suisse & Zühlke aims to bring together biotech founders, investors, pharma innovators, and ecosystem leaders to explore how breakthrough science translates into scalable, real-world impact. The focus is on the full journey from discovery to development and global commercialization, including enabling platforms, partnerships, and technologies such as AI and lab automation.
Designed as a C-level, non-commercial forum, it aims to foster meaningful exchange and collaboration across the biotech ecosystem. The event is free to attend (registration required) and will be followed by an apéro reception with drinks and finger food. Optional lab tours will be available for interested participants, subject to capacity and safety requirements
📅 Date
Monday, 4 May 2026
⏰ Time
18:30 – 21:30
📍 Venue
Superlab Suisse Basel
Hochbergerstrasse 60i, 4057 Basel, Switzerland
Who Should Attend
• Biotech founders & executives
• Venture capital & investment leaders
• Pharma innovation & strategy teams
• Academic entrepreneurs & translational leaders
• Ecosystem builders & decision-makers
Agenda
18:30 – 18:50
Arrival & Superlab Suisse Labtours
18:50 – 19:00
Welcome Note - Dr Jubin Shah & Zhang Xi, CEO
19:00 – 19:45
Panel Discussion: Building the Next Biotech Champions
This panel examines biotech through a company-building and investment lens.
Key topics:
Funding landscape & investor expectations
Venture-building models (VC, venture studios, partnerships)
Scaling from early-stage to global player
Leadership, timing, and market positioning
19:45 – 20:30
Interactive Discussion by Zühlke: From Discovery to Development
This session shifts to the operational and scientific journey of turning discoveries into real therapies. It’s more interactive and ecosystem-driven, focusing on collaboration.
Key themes:
Translating research into development pipelines
Startup–pharma–CDMO collaboration models
AI-enabled drug discovery & enabling technologies
Overcoming bottlenecks in development
20:30– 21:30
Apéro & Networking